Advertisement

Pharmacy

Home Pharmacy
Giving one dose of the varicella vaccine at age 1 and a second dose at ages 4 to 6 is nearly 100 percent effective in preventing varicella

Two-Dose Varicella Vaccine Offers Improved Protection

Adding second inoculation at ages 4 to 6 is almost 100 percent effective
Obese women taking oral contraceptives may be nearly 30 times more likely to develop cerebral venous thrombosis

Cerebral Venous Thrombosis Risk Up in Obese Women on OCPs

Better counseling of obese women needed, including consideration of non-hormonal contraceptives
Clinician communication and prescribing behavior reinforce parents' understanding of antibiotic treatment

Doctor Communication Supports Parents’ Beliefs About Antibiotics

Antibiotic prescriptions confirm parents' beliefs about what indicates illness severity
A combined intervention of optimized analgesic prescription and exercise therapy is feasible and associated with significant reductions in pain and activity limitation in patients with knee osteoarthritis and severe knee pain

Analgesics Plus Exercise Therapy Feasible for Knee OA

Seventy-eight percent of patients could participate in exercise protocol after analgesic use
About 25 percent of patients with infantile hemangioma have rebound growth

Rebound Growth for One in Four With Infantile Hemangioma

Factors linked to rebound growth include age of discontinuation, deep IH, and female gender
Expensive medications are being given far more often to elderly patients with metastatic colorectal cancer

Elderly With Advanced CRC Often Get Costly, Unnecessary Tx

Medications come with many side effects, may add only one month to survival, researchers say
The 21-gene recurrence score (Oncotype DX) seems to accurately identify women with early-stage breast cancer who don't need chemotherapy

Gene Test IDs Breast CA Patients Who May Not Need Chemo

Analysis can help women who won't benefit from additional treatment to avoid side effects
Xalkori (crizotinib) has been approved by the U.S. Food and Drug Administration to treat advanced non-small-cell lung cancer with tumors that have a rare ROS1 gene mutation.

FDA Approves Xalkori for Rare Genetic Form of Lung Cancer

Drug approval expanded to include patients with ROS1-positive NSCLC
Women with diabetes who take insulin appear to have a higher incidence of dense breasts

Insulin Treatment May Up Breast Density in Diabetes Patients

Women on insulin might need extra breast cancer screening
Warfarin treatment for patients with atrial fibrillation may raise the risk of traumatic intracranial bleeding by more than previously reported

Warfarin’s Intracranial Bleed Risk Higher Than Previously Reported

Several factors place patients at increased risk of traumatic intracranial bleeding